12:00 AM
 | 
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Raxibacumab regulatory update

FDA's Anti-Infective Drugs Advisory Committee will meet on Nov. 2 to discuss a BLA from GlaxoSmithKline's Human Genome Sciences Inc. subsidiary for raxibacumab to...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >